Shankara Paneesha

CRISPR screens identify genomic ribonucleotides as a source of PARP-trapping lesions

Michal Zimmermann, Olga Murina, Martin A.M. Reijns et al. · Nature · 2018 · 418 citations · Full text

Life Sciences, Genetics, Molecular Biology +10

Chronic Lymphocytic Leukemia Therapy Guided by Measurable Residual Disease

Talha Munir, David A. Cairns, Adrian Bloor et al. · New England Journal of Medicine · 2023 · 155 citations · Full text

Medicine, Oncology, Pharmacotherapy +12

Antibody responses after first and second Covid-19 vaccination in patients with chronic lymphocytic leukaemia

Helen Parry, Graham McIlroy, Rachel Bruton et al. · Blood Cancer Journal · 2021 · 129 citations · Full text

Veterinary Medicine, Hematology, Immunology +17

Ibrutinib and rituximab versus fludarabine, cyclophosphamide, and rituximab for patients with previously untreated chronic lymphocytic leukaemia (FLAIR): interim analysis of a multicentre, open-label, randomised, phase 3 trial

Peter Hillmen, Alexandra Pitchford, Adrian Bloor et al. · The Lancet Oncology · 2023 · 106 citations · Full text

Medicine, Immunology, Pharmacotherapy +14

Efficacy of venetoclax monotherapy in patients with relapsed chronic lymphocytic leukaemia in the post‐<scp>BCR</scp>inhibitor setting: a<scp>UK</scp>wide analysis

Toby A. Eyre, Amy A. Kirkwood, George Follows et al. · British Journal of Haematology · 2019 · 79 citations · Full text

Medicine, Hematology, Pharmacotherapy +15